Regulation of the adaptor molecule LAT2, an in vivo target gene of AML1/ETO (RUNX1/RUNX1T1), during myeloid differentiation

British Journal of Haematology

Volumn 153, Issue 5, 2011, Pages 612-622

  Duque Afonso, Jesús ^a   Solari, Leticia ^a   Essig, Aitomi ^a   Berg, Tobias ^a,b   Pahl, Heike L ^a   Lübbert, Michael ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Acute myeloid leukaemia; Adaptor molecule; Chromosomal translocations; Myeloid differentiation; Transcription factor

Indexed keywords

ADAPTOR PROTEIN; AML1 ETO PROTEIN; HYBRID PROTEIN; LINKER ACTIVATOR OF T CELL 2 PROTEIN; PHORBOL ESTER; RETINOIC ACID; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE TARGETING; GRANULOCYTE; HUMAN; HUMAN CELL; MALE; MYELOMONOCYTIC LEUKEMIA; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RUNX1 RUNX1T1 GENE; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; CHOLECALCIFEROL; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOCYTES; HUMANS; LEUKEMIA, MYELOID, ACUTE; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; PHORBOL ESTERS; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 79955738749     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08586.x     Document Type: Article

References (35)

1. Berg, T., Fliegauf, M., Burger, J., Staege, M.S., Liu, S., Martínez, N., Heidenreich, O., Burdach, S., Haferlach, T., Werner, M.H. & Lübbert, M. (2008) Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETO. Haematologica, 93, 1728-1733.
2. Brdicka, T., Imrich, M., Angelisova, P., Brdickova, N., Horvath, O., Spicka, J., Hilgert, I., Lusková, P., Dráber, P., Novák, P., Engels, N., Wienands, J., Simeoni, L., Österreicher, J., Aguado, E., Malissen, M., Schraven, B. & Horejsi, V. (2002) Non-T-cell activation linker (NTAL): a transmembrane adaptor protein involved in immunoreceptor signaling. Journal of Experimental Medicine, 196, 1617-1626.
3. Buday, L., Khwaja, A., Sipeki, S., Faragó, A. & Downward, J. (1996) Interactions of Cbl with two adapter proteins, Grb2 and Crk, upon T-cell activation. Journal of Biological Chemistry, 271, 6159-6163.
4. Burel, S.A., Harakawa, N., Zhou, L., Pabst, T., Tenen, D.G. & Zhang, D.E. (2001) Dichotomy of AML1-ETO functions: growth arrest versus block of differentiation. Molecular and Cellular Biology, 21, 5577-5590.
5. Cameron, S., Taylor, D.S., TePas, E.C., Speck, N.A. & Mathey-Prevot, B. (1994) Identification of a critical regulatory site in the human interleukin-3 promoter by in vivo footprinting. Blood, 83, 2851-2859.
6. Chomczynski, P. & Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochemistry, 162, 156-159.
7. Dorrell, C., Takenaka, K., Minden, M.D., Hawley, R.G. & Dick, J.E. (2004) Hematopoietic cell fate and the initiation of leukemic properties in primitive primary human cells are influenced by Ras activity and farnesyltransferase inhibition. Molecular and Cellular Biology, 24, 6993-7002.
8. Erickson, P., Gao, J., Chang, K.S., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J. & Drabkin, H. (1992) Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood, 80, 1825-1831.
9. Fazi, F., Zardo, G., Gelmetti, V., Travaglini, L., Ciolfi, A., Di Croce, L., Rosa, A., Bozzoni, I., Grignani, F., Lo-Coco, F., Pelicci, P.G. & Nervi, C. (2007) Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia. Blood, 109, 4432-4440.
10. Fliegauf, M., Stock, M., Berg, T. & Lübbert, M. (2004) Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETO. Oncogene, 23, 9070-9081.
11. Frank, R., Zhang, J., Uchida, H., Meyers, S., Hiebert, S.W. & Nimer, S.D. (1995) The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene, 11, 2667-2674.
12. Gelmetti, V., Zhang, J., Fanelli, M., Minucci, S., Pelicci, P.G. & Lazar, M.A. (1998) Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Molecular and Cellular Biology, 18, 7185-7191.
13. Janssen, E., Zhu, M., Zhang, W., Koonpaew, S. & Zhang, W. (2003) LAB: a new membrane-associated adaptor molecule in B-cell activation. Nature Immunology, 4, 117-123.
14. Kitamura, T., Koshino, Y., Shibata, F., Oki, T., Nakajima, H., Nosaka, T. & Kumagai, H. (2003) Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Experimental Hematology, 31, 1007-1014.
15. Linggi, B., Müller-Tidow, C., van de Locht, L., Hu, M., Nip, J., Serve, H., Berdel, W.E., van der Reijden, B., Quelle, D.E., Rowley, J.D., Cleveland, J., Jansen, J.H., Pandolfi, P.P. & Hiebert, S.W. (2002) The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Nature Medicine, 8, 743-750.
16. Liu, S., Shen, T., Huynh, L., Klisovic, M.I., Rush, L.J., Ford, J.L., Yu, J., Becknell, B., Li, Y., Liu, C., Vukosavljevic, T., Whitman, S.P., Chang, K.S., Byrd, J.C., Perrotti, D., Plass, C. & Marcucci, G. (2005) Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia. Cancer Research, 65, 1277-1284.
17. Loh, M.L., Sakai, D.S., Flotho, C., Kang, M., Fliegauf, M., Archambeault, S., Mullighan, C.G., Chen, L., Bergstraesser, E., Bueso-Ramos, C.E., Emanuel, P.D., Hasle, H., Issa, J.P., van den Heuvel-Eibrink, M.M., Locatelli, F., Stary, J., Trebo, M., Wlodarski, M., Zecca, M., Shannon, K.M. & Niemeyer, C.M. (2009) Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. Blood, 114, 1859-1863.
18. Lutterbach, B., Westendorf, J.J., Linggi, B., Patten, A., Moniwa, M., Davie, J.R., Huynh, K.D., Bardwell, V.J., Lavinsky, R.M., Rosenfeld, M.G., Glass, C., Seto, E. & Hiebert, S.W. (1998) ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Molecular and Cellular Biology, 18, 7176-7184.
19. de la Luz Sierra, M., Sakakibara, S., Gasperini, P., Salvucci, O., Jiang, K., McCormick, P.J., Segarra, M., Stone, J., Maric, D., Zhu, J., Qian, X., Lowy, D.R. & Tosato, G. (2010) The transcription factor Gfi1 regulates G-CSF signaling and neutrophil development through the Ras activator RasGRP1. Blood, 115, 3970-3979.
20. Maher, J., Baker, D., Dibb, N. & Roberts, I. (1996) Mutant ras promotes haemopoietic cell proliferation or differentiation in a cell-specific manner. Leukemia, 10, 83-90.
21. Müller, A.M., Duque, J., Shizuru, J.A. & Lübbert, M. (2008) Complementing mutations in core binding factor leukemias: from mouse models to clinical applications. Oncogene, 27, 5759-5773.
22. Niemeyer, C.M., Kang, M.W., Shin, D.H., Furlan, I., Erlacher, M., Bunin, N.J., Bunda, S., Finklestein, J.Z., Sakamoto, K.M., Gorr, T.A., Mehta, P., Schmid, I., Kropshofer, G., Corbacioglu, S., Lang, P.J., Klein, C., Schlegel, P.G., Heinzmann, A., Schneider, M., Starý, J., van den Heuvel-Eibrink, M.M., Hasle, H., Locatelli, F., Sakai, D., Archambeault, S., Chen, L., Russell, R.C., Sybingco, S.S., Ohh, M., Braun, B.S., Flotho, C. & Loh, M.L. (2010) Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. Nature Genetics, 42, 794-800.
23. Otto, F., Lübbert, M. & Stock, M. (2003) Upstream and downstream targets of RUNX proteins. Journal of Cell Biology, 89, 9-18.
24. Rebollo, A. & Martínez-A, C. (1999) Ras proteins: recent advances and new functions. Blood, 94, 2971-2980.
25. Sanada, M., Suzuki, T., Shih, L.Y., Otsu, M., Kato, M., Yamazaki, S., Tamura, A., Honda, H., Sakata-Yanagimoto, M., Kumano, K., Oda, H., Yamagata, T., Takita, J., Gotoh, N., Nakazaki, K., Kawamata, N., Onodera, M., Nobuyoshi, M., Hayashi, Y., Harada, H., Kurokawa, M., Chiba, S., Mori, H., Ozawa, K., Omine, M., Hirai, H., Nakauchi, H., Koeffler, H.P. & Ogawa, S. (2009) Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms. Nature, 460, 904-908.
26. Schmidt, M.H. & Dikic, I. (2005) The Cbl interactome and its functions. Nature Reviews Molecular and Cellular Biology, 6, 907-918.
27. Schoch, C., Kohlmann, A., Schnittger, S., Brors, B., Dugas, M., Mergenthaler, S., Kern, W., Hiddemann, W., Eils, R. & Haferlach, T. (2002) Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proceedings of the National Academy of Sciences U S A, 99, 10008-10013.
28. Tedoldi, S., Paterson, J.C., Hansmann, M.L., Natkunam, Y., Rudiger, T., Angelisova, P., Du, M.Q., Roberton, H., Roncador, G., Sanchez, L., Pozzobon, M., Masir, N., Barry, R., Pileri, S., Mason, D.Y., Marafioti, T. & Horejsí, V. (2006) Transmembrane adaptor molecules: a new category of lymphoid-cell markers. Blood, 107, 213-221.
29. Tessarz, A.S., Weiler, S., Zanzinger, K., Angelisova, P., Horejsi, V. & Cerwenka, A. (2007) Non-T-cell activation linker (NTAL) negatively regulates TREM-1/DAP12-induced inflammatory cytokine production in myeloid cells. Journal of Immunology, 178, 1991-1999.
30. Thien, C.B. & Langdon, W.Y. (2005) c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses. Biochemical Journal, 391, 153-166.
31. Tkaczyk, C., Horejsi, V., Iwaki, S., Draber, P., Samelson, L.E., Satterthwaite, A.B., Nahm, D.H., Metcalfe, D.D. & Gilfillan, A.M. (2004) NTAL phosphorylation is a pivotal link between the signaling cascades leading to human mast cell degranulation following Kit activation and Fc epsilon RI aggregation. Blood, 104, 207-214.
32. Volna, P., Lebduska, P., Draberova, L., Simova, S., Heneberg, P., Boubelik, M., Bugajev, V., Malissen, B., Wilson, B.S., Horejsí, V., Malissen, M. & Dráber, P. (2004) Negative regulation of mast cell signaling and function by the adaptor LAB/NTAL. Journal of Experimental Medicine, 200, 1001-1013.
33. Wang, Y., Horvath, O., Hamm-Baarke, A., Richelme, M., Gregoire, C., Guinamard, R., Horejsi, V., Angelisova, P., Spicka, J., Schraven, B., Malissen, B. & Malissen, M. (2005) Single and combined deletions of the NTAL/LAB and LAT adaptors minimally affect B-cell development and function. Molecular and Cellular Biology, 25, 4455-4465.
34. Zhu, M., Liu, Y., Koonpaew, S., Granillo, O. & Zhang, W. (2004) Positive and negative regulation of FcepsilonRI-mediated signaling by the adaptor protein LAB/NTAL. Journal of Experimental Medicine, 200, 991-1000.
35. Zhu, M., Koonpaew, S., Liu, Y., Shen, S., Denning, T., Dzhagalov, I., Rhee, I. & Zhang, W. (2006) Negative regulation of T-cell activation and autoimmunity by the transmembrane adaptor protein LAB. Immunity, 25, 757-768.